In This Study, a Retrospective Analysis Was Conducted to Explore the Risk Factors for Patients Undergoing Pancreaticoduodenal Surgery (PD) to Achieve TO, and a Nomogram Prediction Model Was Further Established to Promote the Standardization and Standardization of PD Surgical Quality Evaluation.

Launched by LUOKAI ZHANG · Jan 2, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the factors that might affect patients undergoing a specific type of surgery called pancreaticoduodenal surgery (PD), which is often needed for conditions like pancreatic cancer and cholangiocarcinoma. Researchers are analyzing past patient data from a hospital in Changzhou to identify what influences the success of this surgery and are creating a tool called a nomogram to help predict outcomes and improve the quality of surgical care.

To be eligible for this study, patients should have undergone successful radical PD surgery for clearly identified tumors and have complete medical records available. Unfortunately, those who had surgery for palliative reasons, have tumor spread, other primary cancers, severe organ issues, or unclear tumor diagnosis after surgery will not be included. Participants in the trial can expect to help advance knowledge in surgical quality, which may lead to better care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients who received radical PD surgery and whose pathological findings were clear tumors;
• • 2. Complete clinical data preservation.
• Exclusion Criteria:
• • 1. Palliative resection; 2. Tumor metastasis or other primary tumors; 3. Combined with severe organ dysfunction; 4. Postoperative pathology was not clear tumor.
• • -